An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

The aim of this study was to assess the prognostic value of pretreatment clinical and laboratory parameters in refractory or relapsed multiple myeloma (MM) patients who have a long-term response to thalidomide (THAL), lasting at least 18 months. The study was carried out on 234 patients who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Hus, I, Dmoszynska, A, Manko, J, Hus, M, Jawniak, D, Soroka-Wojtaszko, M, Hellmann, A, Ciepluch, H, Skotnicki, A, Wolska-Smolen, T, Sulek, K, Robak, T, Konopka, L, Kloczko, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409770/
https://www.ncbi.nlm.nih.gov/pubmed/15520820
http://dx.doi.org/10.1038/sj.bjc.6602225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409770/
https://www.ncbi.nlm.nih.gov/pubmed/15520820
http://dx.doi.org/10.1038/sj.bjc.6602225

Ejemplares similares